On the public citation graph

The Fall in Antibody Response to SARS-CoV-2: a Longitudinal Study of Asymptomatic to Critically Ill Patients Up to 10 Months after Recovery

https://doi.org/10.1128/jcm.01138-21
0 signed · 91 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1001/jamanetworkopen.2020.35234openalex-snapshot
Assessment of Seroprevalence of SARS-CoV-2 and Risk Factors Associated With COVID-19 Infection Among Outpatients in Virginia
inferredcites →https://doi.org/10.1002/rmv.2162openalex-snapshot
Immune response following infection with SARS‐CoV ‐2 and other coronaviruses: A rapid review
inferredcites →https://doi.org/10.1016/j.cca.2020.05.050openalex-snapshot
Diagnostic performances and thresholds: The key to harmonization in serological SARS-CoV-2 assays?
inferredcites →https://doi.org/10.1016/j.ijsu.2014.07.013openalex-snapshot
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for reporting observational studies
inferredcites →https://doi.org/10.1016/s0140-6736(20)31483-5openalex-snapshot
Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study
inferredcites →https://doi.org/10.1016/s0140-6736(21)00575-4openalex-snapshot
Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: a population-level observational study
inferredcites →https://doi.org/10.1016/s1473-3099(20)30943-9openalex-snapshot
Persistence of IgG response to SARS-CoV-2
inferredcites →https://doi.org/10.1038/s41467-020-18450-4openalex-snapshot
A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity
inferredcites →https://doi.org/10.1038/s41467-021-21040-7openalex-snapshot
A multiplex chemiluminescent immunoassay for serological profiling of COVID-19-positive symptomatic and asymptomatic patients
inferredcites →https://doi.org/10.1038/s41591-020-0965-6openalex-snapshot
Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections
inferredcites →https://doi.org/10.1056/nejmc2025179openalex-snapshot
Rapid Decay of Anti–SARS-CoV-2 Antibodies in Persons with Mild Covid-19
inferredcites →https://doi.org/10.1056/nejmoa2026116openalex-snapshot
Humoral Immune Response to SARS-CoV-2 in Iceland
inferredcites →https://doi.org/10.1056/nejmoa2034545openalex-snapshot
Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers
inferredcites →https://doi.org/10.1093/cid/ciaa1343openalex-snapshot
Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19: Serologic Testing (September 2020)
inferredcites →https://doi.org/10.1093/cid/ciab004openalex-snapshot
The Duration, Dynamics, and Determinants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Responses in Individual Healthcare Workers
inferredcites →https://doi.org/10.1101/2020.08.15.20175794openalex-snapshot
SARS-CoV-2 Antibody Responses Correlate with Resolution of RNAemia But Are Short-Lived in Patients with Mild Illness
inferredcites →https://doi.org/10.1101/2021.01.13.21249642openalex-snapshot
Do antibody positive healthcare workers have lower SARS-CoV-2 infection rates than antibody negative healthcare workers? Large multi-centre prospective cohort study (the SIREN study), England: June to November 2020
inferredcites →https://doi.org/10.1126/science.abd7728openalex-snapshot
Robust neutralizing antibodies to SARS-CoV-2 infection persist for months
inferredcites →https://doi.org/10.1126/science.abf4063openalex-snapshot
Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection
inferredcites →https://doi.org/10.1126/sciimmunol.abe0367openalex-snapshot
Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patients
inferredcites →https://doi.org/10.1126/sciimmunol.abe5511openalex-snapshot
Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in COVID-19 patients
inferredcites →https://doi.org/10.1186/s12879-021-05878-2openalex-snapshot
Stringent thresholds in SARS-CoV-2 IgG assays lead to under-detection of mild infections
inferredcites →https://doi.org/10.1371/journal.pmed.0040296openalex-snapshot
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies
inferredcites →https://doi.org/10.1371/journal.pone.0244126openalex-snapshot
Antibody response to SARS-CoV-2 infection in humans: A systematic review
inferredcites →https://doi.org/10.15585/mmwr.mm6947a2openalex-snapshot
Decline in SARS-CoV-2 Antibodies After Mild Infection Among Frontline Health Care Personnel in a Multistate Hospital Network — 12 States, April–August 2020
inferredcites →https://doi.org/10.15585/mmwr.mm7011e3openalex-snapshot
Effectiveness of the Pfizer-BioNTech COVID-19 Vaccine Among Residents of Two Skilled Nursing Facilities Experiencing COVID-19 Outbreaks — Connecticut, December 2020–February 2021
inferredcites →https://doi.org/10.2807/1560-7917.es.2021.26.5.2100092openalex-snapshot
Antibodies to SARS-CoV-2 protect against re-infection during outbreaks in care homes, September and October 2020
inferredcites →https://doi.org/10.3389/fphys.2020.571416openalex-snapshot
Aging, Immunity, and COVID-19: How Age Influences the Host Immune Response to Coronavirus Infections?

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4010766openalex-extracted
Seroprevalence and Seroreversion of SARS-CoV-2 Antibodies in a Cohort of Health Care Workers, Kinshasa, Democratic Republic of Congo
inferred← citeshttps://doi.org/10.2139/ssrn.4072040openalex-extracted
Persistent Maintenance of Atypical Memory B Cells Following SARS-CoV-2 Infection and Vaccination Recall Response
inferred← citeshttps://doi.org/10.2139/ssrn.4196961openalex-extracted
Therapeutic Effects of Clarithromycin Combined with Molnupiravir in Management of Mild to Moderate COVID-19 Hospitalized Patients: A Case Control Study
inferred← citeshttps://doi.org/10.1002/hsr2.71038openalex-snapshot
Determinants of Antibody Reactivity in COVID‐19: A Case‐Control Study in a Middle Eastern Cohort
inferred← citeshttps://doi.org/10.1002/iid3.1116openalex-snapshot
Mucosal response of inactivated and recombinant COVID‐19 vaccines in Congolese individuals
inferred← citeshttps://doi.org/10.1002/jmv.27784openalex-snapshot
The kinetics and predictors of anti‐SARS‐CoV‐2 antibodies up to 8 months after symptomatic COVID‐19: A Czech cross‐sectional study
inferred← citeshttps://doi.org/10.1007/s00430-023-00776-7openalex-snapshot
COVID-19 recurrence is related to disease-early profile T cells while detection of anti-S1 IgG is related to multifunctional T cells
inferred← citeshttps://doi.org/10.1016/j.biopha.2025.117936openalex-snapshot
The comprehensive insights into the B-cells-mediated immune response against COVID-19 infection amid the ongoing evolution of SARS-CoV-2
inferred← citeshttps://doi.org/10.1016/j.chaos.2022.112630openalex-snapshot
How many asymptomatic cases were unconfirmed in the US COVID-19 pandemic? The evidence from a serological survey
inferred← citeshttps://doi.org/10.1016/j.clinbiochem.2024.110859openalex-snapshot
Characterizing the SARS-CoV-2 antibody response and associations with patient factors: Serological profiling of participants enrolled in the GENCOV study
inferred← citeshttps://doi.org/10.1016/j.cmi.2022.03.016openalex-snapshot
Post–COVID-19 syndrome and humoral response association after 1 year in vaccinated and unvaccinated patients
inferred← citeshttps://doi.org/10.1016/j.cmi.2022.06.003openalex-snapshot
‘Post-COVID-19 syndrome and humoral response association after one year in vaccinated and unvaccinated patients’: authors' response
inferred← citeshttps://doi.org/10.1016/j.cmi.2023.12.017openalex-snapshot
Antibody response and risk of reinfection over 2 years among the patients with first wave of COVID-19
inferred← citeshttps://doi.org/10.1016/j.diagmicrobio.2022.115659openalex-snapshot
Lower persistence of anti-nucleocapsid compared to anti-spike antibodies up to one year after SARS-CoV-2 infection
inferred← citeshttps://doi.org/10.1016/j.ebiom.2021.103597openalex-snapshot
Immunological response after mild COVID-19: How long will it last?
inferred← citeshttps://doi.org/10.1016/j.idm.2024.09.002openalex-snapshot
Planning and adjusting the COVID-19 booster vaccination campaign to reduce disease burden
inferred← citeshttps://doi.org/10.1016/j.ijregi.2025.100736openalex-snapshot
Persistence of SARS-CoV-2 Antibody Response across Diverse Clinical Settings in Oman: Insights from a Prospective ELISA-based Study
inferred← citeshttps://doi.org/10.1016/j.jmii.2023.03.004openalex-snapshot
Longitudinal neutralizing antibody responses after SARS-CoV-2 infection: A convalescent cohort study in Taiwan
inferred← citeshttps://doi.org/10.1016/j.rpsm.2022.05.008openalex-snapshot
Mental health symptoms one year after acute COVID-19 infection: Prevalence and risk factors
inferred← citeshttps://doi.org/10.1016/j.virol.2025.110710openalex-snapshot
Impact of baseline humoral immunity on treatment outcomes with molnupiravir in the MOVe-OUT randomized, controlled trial
inferred← citeshttps://doi.org/10.1017/ipm.2023.53openalex-snapshot
COVID-19-induced neuropsychiatric symptoms can persist long after acute infection: a 2-year prospective study of biobehavioral risk factors and psychometric outcomes
inferred← citeshttps://doi.org/10.1038/s41423-023-01095-wopenalex-snapshot
B-cell and antibody responses to SARS-CoV-2: infection, vaccination, and hybrid immunity
inferred← citeshttps://doi.org/10.1038/s41467-026-68557-3openalex-snapshot
Mobility-driven synthetic contact matrices as a scalable solution for real-time pandemic response modeling
inferred← citeshttps://doi.org/10.1038/s41598-023-32441-7openalex-snapshot
Analysis of fatality impact and seroprevalence surveys in a community sustaining a SARS-CoV-2 superspreading event
inferred← citeshttps://doi.org/10.1093/ofid/ofac613openalex-snapshot
Persistence of Neutralizing Antibodies and Clinical Protection up to 12 Months After Severe Acute Respiratory Syndrome Coronavirus 2 Infection in the Elderly
inferred← citeshttps://doi.org/10.1093/ofid/ofad364openalex-snapshot
Post-COVID-19 Syndrome 2 Years After the First Wave: The Role of Humoral Response, Vaccination and Reinfection
inferred← citeshttps://doi.org/10.1097/qai.0000000000003924openalex-snapshot
Adverse Birth Outcomes Associated With SARS-CoV-2 Infection Among Pregnant Women With and Without HIV: A Longitudinal Cohort Study
inferred← citeshttps://doi.org/10.1101/2022.06.28.22277034openalex-snapshot
Differential COVID-19 infection rates in children, adults, and elderly: evidence from 38 pre-vaccination national seroprevalence studies
inferred← citeshttps://doi.org/10.1101/2022.08.22.22278930openalex-snapshot
Correlation of patient serum IgG, IgA and IgM antigen binding with COVID-19 disease severity using multiplexed SARS-CoV-2 antigen microarray and maintained relative IgA and IgM antigen binding over time
inferred← citeshttps://doi.org/10.1101/2025.06.29.25330529openalex-snapshot
Factors influencing SARS-CoV-2 IgG test sensitivity: A Bayesian analysis of seroconversion and reversion by time since infection, test, age and disease severity
inferred← citeshttps://doi.org/10.1113/ep092850openalex-snapshot
Persistence of fatigue in the absence of pathophysiological mechanisms in some patients more than 2 years after the original SARS‐CoV‐2 infection
inferred← citeshttps://doi.org/10.1128/jvi.00760-22openalex-snapshot
Persistent Maintenance of Intermediate Memory B Cells Following SARS-CoV-2 Infection and Vaccination Recall Response
inferred← citeshttps://doi.org/10.1177/03946320231187744openalex-snapshot
Anti-nucleocapsid IgG antibodies in SARS-CoV-2 recovered health care workers: One year follow-up study
inferred← citeshttps://doi.org/10.1186/s12879-022-07786-5openalex-snapshot
Evaluation of qualitative and semi-quantitative cut offs for rapid diagnostic lateral flow test in relation to serology for the detection of SARS-CoV-2 antibodies: findings of a prospective study
inferred← citeshttps://doi.org/10.1186/s12879-023-08425-3openalex-snapshot
Long-term evaluation of the seroprevalence of SARS-CoV-2 IgG and IgM antibodies in recovered patients: a meta-analysis
inferred← citeshttps://doi.org/10.1186/s12879-023-08923-4openalex-snapshot
A stronger antibody response in increased disease severity of SARS-CoV-2
inferred← citeshttps://doi.org/10.1186/s12961-023-01055-wopenalex-snapshot
Lessons learnt while designing and conducting a longitudinal study from the first Italian COVID-19 pandemic wave up to 3 years
inferred← citeshttps://doi.org/10.1186/s12979-022-00271-2openalex-snapshot
Association between inflammatory cytokines and anti-SARS-CoV-2 antibodies in hospitalized patients with COVID-19
inferred← citeshttps://doi.org/10.1186/s41043-024-00536-0openalex-snapshot
COVID-19 seroprevalence cohort survey among health care workers and their household members in Kinshasa, DR Congo, 2020–2022
inferred← citeshttps://doi.org/10.1371/journal.pone.0281689openalex-snapshot
Immunoglobulins response of COVID-19 patients, COVID-19 vaccine recipients, and random individuals
inferred← citeshttps://doi.org/10.1371/journal.pone.0283537openalex-snapshot
A new multiplex SARS-CoV-2 antigen microarray showed correlation of IgG, IgA, and IgM antibodies from patients with COVID-19 disease severity and maintenance of relative IgA and IgM antigen binding over time
inferred← citeshttps://doi.org/10.1371/journal.pone.0328144openalex-snapshot
Factors influencing SARS-CoV-2 IgG test sensitivity: A Bayesian analysis of seroconversion and seroreversion by time since infection, test, age and disease severity
inferred← citeshttps://doi.org/10.21203/rs.3.rs-3710665/v1openalex-snapshot
Revisiting a COVID-19 seroprevalence cohort survey among health care workers and their household members in Kinshasa, DR Congo, 2020-2022
inferred← citeshttps://doi.org/10.21203/rs.3.rs-3824689/v1openalex-snapshot
High-resolution kinetics and cellular determinants of antibody response to SARS-CoV-2 over two years after COVID-19 vaccination
inferred← citeshttps://doi.org/10.21203/rs.3.rs-4199263/v1openalex-snapshot
Cycle threshold values are associated with adaptive immunity to COVID-19– a case-control study in Qatar
inferred← citeshttps://doi.org/10.2169/internalmedicine.9628-22openalex-snapshot
The Proportion of Long-term Response to Anti-N IgG Antibody after 12 Months for COVID-19 Subclinical Infections and a Longitudinal Survey for COVID-19 Subclinical Infections in 2021
inferred← citeshttps://doi.org/10.22207/jpam.17.1.56openalex-snapshot
Seroconversion in COVID-19 Infection and Comparison of Antibody Responses in Symptomatic Versus Asymptomatic Individuals
inferred← citeshttps://doi.org/10.3389/fimmu.2025.1684704openalex-snapshot
CXCL9 and CXCL10 support the exacerbated humoral response in recovered COVID-19 patients who developed acute respiratory distress syndrome by promoting plasma cell differentiation, whereas CXCL9 also induces CD40L and CXCR3 upregulation on T helper cells
inferred← citeshttps://doi.org/10.3389/fmed.2022.916241openalex-snapshot
Human IgG antibody responses to severe acute respiratory syndrome coronavirus 2 viral antigens receptor-binding domain, spike, and nucleocapsid, in vaccinated adults from Merida, Mexico
inferred← citeshttps://doi.org/10.3390/children11081011openalex-snapshot
Severe Post-Viral Polymyositis after COVID-19 in Childhood: A Case Report and Literature Review
inferred← citeshttps://doi.org/10.3390/v15040917openalex-snapshot
Dynamics of SARS-CoV-2 Antibody Responses up to 9 Months Post-Vaccination in Individuals with Previous SARS-CoV-2 Infection Receiving Inactivated Vaccines
inferred← citeshttps://doi.org/10.36922/jctr.00075openalex-snapshot
Effect of combination of molnupiravir with clarithromycin on blood biomarkers in patients with mild-to-moderate COVID-19
inferred← citeshttps://doi.org/10.4049/jimmunol.2101156openalex-snapshot
SARS-CoV-2 Antibody Response Is Associated with Age and Body Mass Index in Convalescent Outpatients
inferred← citeshttps://doi.org/10.4236/crcm.2021.109029openalex-snapshot
Persistence of Anti-SARS-CoV-2 IgM Antibody up to 8 Months Post-COVID-19
inferred← citeshttps://doi.org/10.55705/cmbr.2022.345025.1047openalex-snapshot
Current trends and new methods of detection of SARS-CoV-2 infection
inferred← citeshttps://doi.org/10.6084/m9.figshare.19313699openalex-snapshot
Additional file 1 of Association between inflammatory cytokines and anti-SARS-CoV-2 antibodies in hospitalized patients with COVID-19
inferred← citeshttps://doi.org/10.6084/m9.figshare.24472440openalex-snapshot
Additional file 1 of Lessons learnt while designing and conducting a longitudinal study from the first Italian COVID-19 pandemic wave up to 3 years
inferred← citeshttps://doi.org/10.6084/m9.figshare.24472593openalex-snapshot
Additional file 2 of Lessons learnt while designing and conducting a longitudinal study from the first Italian COVID-19 pandemic wave up to 3 years
inferred← citeshttps://doi.org/10.6084/m9.figshare.26634294openalex-snapshot
Additional file 3 of Lessons learnt while designing and conducting a longitudinal study from the first Italian COVID-19 pandemic wave up to 3 years
inferred← citeshttps://doi.org/10.7189/jogh.13.06004openalex-snapshot
Differential COVID-19 infection rates in children, adults, and elderly: Systematic review and meta-analysis of 38 pre-vaccination national seroprevalence studies
inferred← citeshttps://doi.org/10.7554/elife.94475openalex-snapshot
Improving SARS-CoV-2 variants monitoring in the absence of genomic surveillance capabilities: a serological study in Bolivian blood donors in October 2021 and June 2022
inferred← citeshttps://doi.org/10.7554/elife.94475.2openalex-snapshot
Improving SARS-CoV-2 variants monitoring in the absence of genomic surveillance capabilities: a serological study in Bolivian blood donors in October 2021 and June 2022
inferred← citeshttps://doi.org/10.7554/elife.94475.3openalex-snapshot
Improving SARS-CoV-2 variants monitoring in the absence of genomic surveillance capabilities: a serological study in Bolivian blood donors in October 2021 and June 2022
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.